Nexvet Biopharma plc 4
4 · Nexvet Biopharma plc · Filed Apr 4, 2016
Insider Transaction Report
Form 4
Gunn George W
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2016-03-31$0.13/sh+500$63→ 12,900 total - Exercise/Conversion
Restricted Share Units
2016-03-31−500→ 4,000 totalExercise: $0.13From: 2016-03-31Exp: 2019-07-01→ Ordinary Shares (500 underlying)
Footnotes (1)
- [F1]500 of the Restricted Share Units vested and became convertible on 3/31/16, and 500 Restricted Share Units shall vest and become convertible on each of 6/30/16, 9/30/16, 12/31/16, 3/31/17, 6/30/17, 9/30/17, 12/31/17 and 3/31/18 in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting.